Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer.
Papewalis, C
Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. [electronic resource] - Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme Oct 2009 - 752-6 p. digital
Publication Type: Journal Article
1439-4286
10.1055/s-0029-1224116 doi
Carcinoma--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Dose-Response Relationship, Drug
Everolimus
Humans
Immunosuppressive Agents--pharmacology
Proliferating Cell Nuclear Antigen--genetics
Protein Kinases--genetics
RNA--chemistry
Reverse Transcriptase Polymerase Chain Reaction
Sirolimus--analogs & derivatives
TOR Serine-Threonine Kinases
Thyroid Neoplasms--drug therapy
Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. [electronic resource] - Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme Oct 2009 - 752-6 p. digital
Publication Type: Journal Article
1439-4286
10.1055/s-0029-1224116 doi
Carcinoma--drug therapy
Cell Line, Tumor
Cell Proliferation--drug effects
Dose-Response Relationship, Drug
Everolimus
Humans
Immunosuppressive Agents--pharmacology
Proliferating Cell Nuclear Antigen--genetics
Protein Kinases--genetics
RNA--chemistry
Reverse Transcriptase Polymerase Chain Reaction
Sirolimus--analogs & derivatives
TOR Serine-Threonine Kinases
Thyroid Neoplasms--drug therapy